glp-1 side effects and risks Peptide/GLP-1 Complications: 11 Hidden You Must Know Struggling with GLP-1 therapy side
Description
Beta-Cell Function: Pancreatic beta-cell function and diabetes progression have an inverse relationship
Rising patient awareness and improving affordability also contribute to expanding GLP-1 drug uptake
The effectiveness of its GIP receptor antagonism is still under investigation
Considering these preclinical studies, an ASO directed at PNPLA3, called ION839 (AZD 2693), is currently in phase I clinical investigation in patients with MASH carrying the I148M risk alleles of PNPLA3 (NCT04483947)
A comprehensive assessment by your Klinic provider will confirm the suitability of this treatment based on your health profile
The placebo group lost 2.4%
